Pancreatic Cancer Research

ResearcherGeneral Hospital of Central Theater CommandActive in the last 2 years

Weidong Jin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2939-6278; OpenAlex author ID A5101698566. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Clinicopathological Characteristics, Prognosis, and Correlated Tumor Cell Function of Tropomodulin-3 in Pancreatic Adenocarcinoma. Last author DOI 10.2174/1386207326666230810142646↗
  2. Retraction of "SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis". Last author DOI 10.1515/med-2023-0890↗
  3. SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis. Last author DOI 10.1515/med-2022-0418↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhonghu Li · 3 shared papers, 2022–2024 · strength 0.63
  2. Jianxin Zhang · 2 shared papers, 2022–2024 · strength 0.41
  3. Zhiyong Zhang · 2 shared papers, 2022–2023 · strength 0.40
  4. Bin Zhong · 1 shared paper, 2024 · strength 0.23
  5. Tao Zhang · 1 shared paper, 2024 · strength 0.23
  6. Jianxin Zhang · 1 shared paper, 2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.